scholarly journals Dose-Volume Correlates of Patient-Reported Trismus in Long-Term Oropharyngeal Cancer Survivors after IMRT

Author(s):  
M. Kamal ◽  
C. Rock ◽  
S.R. Grant ◽  
J. Zaveri ◽  
R. Granberry ◽  
...  

Cancer ◽  
2021 ◽  
Author(s):  
Puja Aggarwal ◽  
Katherine A. Hutcheson ◽  
Adam S. Garden ◽  
Frank E. Mott ◽  
Charles Lu ◽  
...  




2019 ◽  
Author(s):  
Duc Ha ◽  
Andrew L. Ries ◽  
Jeffrey J. Swigris

AbstractRationale/ObjectiveQuality of life (QoL) is an important issue in lung cancer survivors. We aimed to identify determinants of QoL in lung cancer survivors eligible for long-term cure.MethodsWe performed an exploratory analysis of a cross-sectional study of consecutive lung cancer survivors who completed curative-intent treatment ≥1 month previously. Variables tested included demographic, clinical, physiologic, and symptom-specific patient-reported outcome measures. We defined the primary outcome as a previously-validated cancer-specific QoL measure – the European Organization for Research and Treatment of Cancer QoL Questionnaire Core 30 (C30) summary score. We also verified our findings with the C30 global health status/QoL subscale and a summated score of lung cancer-specific QoL from the EORTC-Lung Cancer Module 13.ResultsIn 75 enrolled participants, measures of fatigue, depression, sleep difficulties, and dyspnea were statistically significant determinants of the C30 summary score in multivariable linear regression analyses. Together, these four symptoms accounted for approximately 85% of the variance in cancer-specific QoL (p<0.001). When we verified our findings with global QoL and lung cancer-specific QoL, fatigue and dyspnea were consistent determinants of QoL.ConclusionsWe found four symptoms – dyspnea, fatigue, depression, and sleep difficulties – that are important determinants of and together accounted for almost all of the variance in cancer-specific QoL in lung cancer survivors eligible for long-term cure. These findings have implications to reduce symptom burden and improve function and QoL in these patients.





2020 ◽  
Vol 24 ◽  
pp. 71-78 ◽  
Author(s):  
Sonja Stieb ◽  
Ismael Perez-Martinez ◽  
Abdallah S.R. Mohamed ◽  
Stockton Rock ◽  
Nimit Bajaj ◽  
...  


2017 ◽  
Vol 35 (15_suppl) ◽  
pp. e21611-e21611 ◽  
Author(s):  
Salman Ali Eraj ◽  
Mona K Jomaa ◽  
Crosby Douglas Rock ◽  
Abdallah Mohamed ◽  
Adam S. Garden ◽  
...  

e21611 Background: Given the potential for older patients (pts) to experience exaggerated toxicity and symptoms, this study was performed to characterize pt reported outcomes (PROs) in older pts following definitive radiation therapy (RT) for oropharyngeal cancer (OPC). Methods: Disease-free head and neck cancer survivors ( > 6 mos. since tx) were eligible for participation in a questionnaire-based study. Participants completed the MD Anderson Symptom Inventory-Head and Neck module (MDASI-HN). Those who had been treated for OPC with definitive RT (w/ or w/o systemic therapy) and were > 65 y/o at time of RT were included. Individual and overall symptom severity and clinical variables were analyzed. Results: Of the 79 participants analyzed, 82% were male, 95% white, 41% T3/4 disease, 39% RT alone, 27% induction chemotherapy, 52% concurrent, and 18% both, and 96% IMRT. Median age at the time of RT was 71 yrs. (range: 65-85); median time from end of RT to MDASI-HN completion was 46 mos. (2/3 > 24 mos.). The top 5 MDASI-HN items rated most severe in terms of mean (±SD) ratings (0-10 scale) were dry mouth (3.48±2.95), taste (2.81±3.29), swallowing (2.59±2.96), mucus in mouth/throat (2.04±2.68), and choking (1.30±2.38) reported at moderate to severe levels (≥5) by 35, 29, 29, 18, and 13%, respectively. Thirty-nine % reported none (0) or no more than mild (1-4) symptoms across all 22 MDASI-HN symptoms items, and 38% had at least one item rated as severe (≥7). Hierarchal cluster analysis resulted in 3 patient groups: 1) ~75% with generally no to moderate symptom burden, 2) ~25% with moderate to severe ratings for a subset of classically RT-related symptoms (e.g. dry mouth, mucus, swallow, taste), and 3) only 2 pts with severe ratings of nearly all items. Subgroup comparisons will be presented. Conclusions: The overall long-term symptom burden seen in this older OPC cohort was largely favorable, yet a higher symptom group (~25%) with a distinct pattern of mostly local symptoms was identified. We have implemented the routine use of symptom assessment tools as part of OPC survivorship programs and plan to explore age-dose-modeling of symptoms identified and associated normal structures.



Author(s):  
Puja Aggarwal ◽  
Katherine A. Hutcheson ◽  
Adam S. Garden ◽  
Frank E. Mott ◽  
Ryan P. Goepfert ◽  
...  




2018 ◽  
Vol 144 (11) ◽  
pp. 1066 ◽  
Author(s):  
Puja Aggarwal ◽  
Jhankruti S. Zaveri ◽  
Ryan P. Goepfert ◽  
Qiuling Shi ◽  
Xianglin L. Du ◽  
...  


Head & Neck ◽  
2015 ◽  
Vol 37 (4) ◽  
pp. E56-E62 ◽  
Author(s):  
Katherine A. Hutcheson ◽  
Margaret M. Yuk ◽  
F. Christopher Holsinger ◽  
G. Brandon Gunn ◽  
Jan S. Lewin


Sign in / Sign up

Export Citation Format

Share Document